2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab.

Nadig N, Bhimraj A, Cawcutt K, Chiotos K, Dzierba AL, Kim AY, Martin GS, Pearson JC, Shumaker AH, Baden LR, Bedimo R, Cheng VC, Chew KW, Daar ES, Glidden DV, Hardy EJ, Johnson S, MacBrayne C, Nakamura MM, Oliveira CR, Riley L, Shafer RW, Shoham S, Tebas P, Tien PC, Willis Z, Wolf J, Loveless J, Falck-Ytter Y, Morgan RL, Gandhi RT